SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 54.50 |
| Enterprise Value ($M) | 29.91 |
| Book Value ($M) | 134.05 |
| Book Value / Share | 18.37 |
| Price / Book | 0.41 |
| NCAV ($M) | 126.34 |
| NCAV / Share | 17.32 |
| Price / NCAV | 0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.63 |
| Return on Assets (ROA) | -0.38 |
| Return on Equity (ROE) | -0.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.65 |
| Current Ratio | 7.65 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 156.38 |
| Assets | 164.09 |
| Liabilities | 30.04 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Tang Capital Management Llc | 9.90 | ||
| 13G/A | BlackRock, Inc. | 1.10 | -82.76 | |
| 13G | Barclays Plc | 5.27 | ||
| 13G/A | Avidity Partners Management LP | 6.90 | -25.90 | |
| 13G/A | Orbimed Advisors Llc | 2.70 | -44.87 | |
| 13G/A | Prosight Management, LP | 4.60 | -17.38 | |
| 13G/A | Suvretta Capital Management, Llc | 9.90 | 104.54 | |
| 13G/A | State Street Corp | 1.54 | -73.76 | |
| 13G/A | Millennium Management Llc | 4.00 | -22.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,196 | 15,322 | 20.86 | |
| 5,389 | 18,799 | 28.67 | |
| 7,109 | 44,039 | 16.14 | |
| 6,775 | 47,681 | 14.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KPRX – Kiora Pharmaceuticals, Inc. | KRRO – Korro Bio, Inc. |
| KTTA – Pasithea Therapeutics Corp. | LEXX – Lexaria Bioscience Corp. |
| LFVN – LifeVantage Corporation |
Financial data and stock pages provided by
Fintel.io